BALTIMORE, April 26, 2024 /7Newswire — Attorneys for Milberg Coleman Bryson Phillips Grossman (“Milberg”) have filed a class action lawsuit over the collapse of the Francis Scott Key Bridge in Baltimore and the losses it has caused to Baltimore businesses. Lead plaintiffs Karen Austin and Charles Austin, who run American Publishing LLC, are the first business owners to sue for the economic …

Continue reading “Baltimore Business Owners File Bridge Collapse Lawsuit”

SOUTHLAKE, Texas, April 26, 2024 /7Newswire — Renibus Therapeutics® (“Renibus”), a clinical-stage biopharmaceutical company focusing on the prevention and treatment of cardio, renal and metabolic diseases, today announced its participation at two prestigious medical conferences: the American Association for Thoracic Surgery (AATS) 104th Annual Meeting and the Society of Cardiovascular Anesthesiologists (SCA) 46th Annual Meeting, both taking place …

Continue reading “Renibus Therapeutics Announces Oral Presentations on RBT-1 at AATS and SCA Medical Conferences”

LONDON, April 26, 2024 /7Newswire — Stafford Capital Partners (“Stafford“), a leading international private markets investment and advisory group, with USD$7.9b under management has launched its flagship Private Equity Decarbonization program tailored for private equity investors who aspire to reduce the carbon footprint of their portfolios and contribute towards achieving their net zero targets while benefitting from the …

Continue reading “Stafford Capital Partners launches flagship Private Equity Decarbonization Program”

WILLIAMSPORT, Pa., April 26, 2024 /7Newswire — On April 25, 2024, the Board of Directors of Woodlands Financial Services Company (OTC Pink: WDFN) declared a quarterly cash dividend of twenty-nine cents per share on its common stock, payable on May 24, 2024, to shareholders of record as of May 10, 2024. Woodlands Financial Services Company is a financial services holding …

Continue reading “Woodlands Financial Services Company Announces Second Quarter Cash Dividend”

MILFORD, Mass., April 26, 2024 /7Newswire — Nitto Denko Avecia Inc. and Nitto Denko Avecia Pharma Services (Nitto Avecia), a global leader in contract development and manufacturing of oligonucleotides for the therapeutic market announced today that Tammy Cooper will be appointed President of Nitto Avecia effective June 21, 2024. Currently, Ms. Cooper is Vice President, Business …

Continue reading “New President Appointed for Nitto Denko Avecia Inc.”